aldophosphamide has been researched along with Liver Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, LW; Black, KC; Chen, TL; Colvin, OM; Grochow, LB; Kennedy, MJ; Kiraly, SB | 1 |
Chen, J; Tsukamoto, N; Yoshida, A | 1 |
2 other study(ies) available for aldophosphamide and Liver Neoplasms
Article | Year |
---|---|
Nonlinear pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide/aldophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Bone Marrow Transplantation; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Humans; Liver Neoplasms; Middle Aged; Nonlinear Dynamics; Phosphoramide Mustards; Thiotepa | 1997 |
Enhanced expressions of glucose-6-phosphate dehydrogenase and cytosolic aldehyde dehydrogenase and elevation of reduced glutathione level in cyclophosphamide-resistant human leukemia cells.
Topics: Aldehyde Dehydrogenase; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Carcinoma, Hepatocellular; Cisplatin; Colonic Neoplasms; Cyclophosphamide; Cytoplasm; Drug Resistance, Neoplasm; Enzyme Induction; Gene Expression Regulation, Leukemic; Glucosephosphate Dehydrogenase; Glutathione; Humans; Isoenzymes; K562 Cells; Liver Neoplasms; Neoplasm Proteins; Oxidation-Reduction; Phosphoramide Mustards; Protein Synthesis Inhibitors; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured | 1998 |